The current American Joint Cancer Committee (AJCC) staging system for salivary gland tumors does not include histology and grade in its classification despite their proven prognostic importance. We ...

ORLANDO, Florida – Cancer staging is the "common language of cancer" and has undergone some important changes that officially debut in January 2018, said a presenter here at the National Comprehensive ...

To describe a new method, the Optical Coherence Tomography (OCT) Glaucoma Staging System, for classifying retinal nerve fiber layer (RNFL) damage assessed with OCT. The OCT Glaucoma Staging System was ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

An international consortium of Huntington disease (HD) experts has developed the first-ever staging system for a genetic neurologic condition ― an important step toward developing new therapeutics to ...

Please provide your email address to receive an email when new articles are posted on . The authors posit the Fine and Gray (FG) Competing Risk model may be a welcome addition to the current staging ...

Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for ...

Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Activity Clinical and laboratory ...

Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for ...

Before therapy commences for any cancer patient, 3 essential factors should be known: the site of origin, the histological type (including grade) and the extent or stage of the cancer. Cancer staging ...

The development and validation of a staging system for non-metastatic prostate cancer could help doctors and patients assess treatment options, as well as improve clinical trials. Doctors and ...